baber/WOPTO huggingface dataset:
Patent AT-E382220-T1 (AT)
Inventor: OOMS DIRK
IPC: H04L12/701
Filed: 1999-10-12
Granted: 2008-01-15
Abstract: To compress a list of destination addresses (A.B.C.D, A.B.C.E, A.F.G.H) of a connectionless multicasted message, addresses (A.B.C.D, A.B.C.E) that have a common prefix (A.B.C) are replaced with a single compound address (A.B.CäD,Eü). This compound address (A.B.CäD,Eü) is constituted by the common prefix (A.B.C) and a list of suffixes (äD,Eü) of these addresses (A.B.C.D, A.B.C.E) that have a common prefix (A.B.C). The compression technique may be applied iteratively and in addition to reducing the overhead required for multicasting, enables faster routing table look-up. <IMAGE>
Patent AT-E208937-T1 (AT)
Inventor: KLAPKA TIMOTHY J
IPC: G07G1/12
Filed: 1999-02-17
Granted: 2001-11-15
Abstract: A method and system for using a frequent shopper card as a phone calling card including (a) issuing a transfer certificate with a predetermined phone time and having a first personal identification number, at a terminal; and (b) adding the predetermined phone time to an account, associated with the frequent shopper card having a second personal identification number, based on the first personal identification number, at a server. The server includes a memory containing a data structure for storing information relating to using the frequent shopper card as a phone calling card. The memory includes fields which store the account information associated with the frequent shopper card, and fields which store the first and second personal identification numbers. A computer program product includes a computer storage medium having a computer program code mechanism embedded in the computer storage medium for causing a computer to allow the frequent shopper card to be used as a phone calling card. The computer program code mechanism includes a first code device configured to issue the transfer certificate with the predetermined phone time, at the terminal; and a second code device configured to add the predetermined phone time to the account, at the server.
Patent AT-E301453-T1 (AT)
Inventor: BRUZZESE TIBERIO
IPC: A61K9/08
Filed: 1999-03-11
Granted: 2005-08-15
Abstract: New injectable pharmaceutical formulations are described, containing a partricin derivative in the form of a free base as the active ingredient, or a pharmaceutically acceptable water-soluble salt thereof in a solubilizing/dispersing medium made up of a lipid and/or phospholipid emulsion in water, a procedure to obtain them, and the use of the formulations in the treatment of phathologies sensitive to the action of partricin derivatives.
Patent AT-E317427-T1 (AT)
Inventor: BARTHOLEYNS JACQUES
IPC: C12Q1/02
Filed: 1999-03-29
Granted: 2006-02-15
Abstract: The invention relates to monocyte derived cells, in a purified form and substantially free of contaminants, presenting antigenic epitopes on their membranes after interiorization and processing of at least an antigen-antibody complex formed between an antigen and an antibody, under appropriate conditions, said epitopes corresponding to proteolytic degradation products of said antigen, with said antibody being directed against a tumor or against an infectious agent, and with said antigen being fragments of tumor or of infectious agent, including membranes or tumor apoptotic bodies, or purified tumor or infectious antigens or being recombinant tumor or infectious antigens.
Patent AT-E375609-T1 (AT)
Inventor: REICHLE HANS
IPC: H01R13/11
Filed: 1999-07-13
Granted: 2007-10-15
Abstract: A cable terminal contract assembly (3) encompasses two spaced apart tongues (4) with contact springs (7) exhibiting contact points (8), wherein the longitudinal edges of the tongues are intended for the insertable, positive meshing with guide grooves of one of the chambers of a multiple-connection strap. The tongues (4) exhibit wire connecting means at the free end, insulation-piercing connecting devices (5), and are connected on the inner end by a web (6) with a narrow width. The contact assembly is a through contact that is transformable into a separating contact by separating the web, or into a switching contact by inserting an isolating piece or via molding. The connection strap casing can be produced as a one-piece plastic body.
Patent AT-E321859-T1 (AT)
Inventor: RIBAUDO RANDALL K
IPC: A61K38/00
Filed: 1999-06-03
Granted: 2006-04-15
Abstract: beta 2-microglobulin fusion proteins and modified forms of  beta 2-microglobulin are disclosed. The fusion proteins are shown to incorporate onto the surface of MHC I expressing mammalian cells and to cause an increased cytotoxic T-cell response to antigens presented by such cells. The fusion proteins are useful in methods of tumor therapy. Modified forms of human  beta 2-microglobulin, particularly a form having a serine to valine transition at amino acid position 55 of the mature protein are shown to have an enhanced affinity for MHC I heavy chain, and are useful both in the disclosed fusion proteins and as a vaccine adjuvant where enhanced cytotoxic T-cell response is desired.
Patent AT-E303783-T1 (AT)
Inventor: FELICELLI ROBERT
IPC: A61J3/00
Filed: 1999-06-04
Granted: 2005-09-15
Abstract: A container for holding a concentrated drug for a mixing system includes a barrel with a cover structure including a delivery passage at a first end and a closing structure at an opposite, second end. A female Luer lock fitting defines the delivery passage at the first end. The closing structure and the female Luer lock fitting can each be formed integrally with the barrel, or the closing structure can be a slidable stopper. The closing structure may also include a holder. The holder is constructed to move between two positions. In the first position, the holder is in a elevated position on the second end of the barrel. The barrel can vent vapor around the cover piece. In the second position, the holder is depressed onto the barrel and it cannot vent vapor. The cover structure may include a snap-on cover piece to fit over the first end. The cover piece includes the female luer lock fitting. The cover piece functions similar to the holder.The container can be used in a mixing system which includes a diluent syringe with a barrel having a discharge passage at a first end, and a piston slidably and sealingly disposed in the diluent syringe barrel to define a diluent chamber adjacent the discharge passage. The syringe includes a male Luer lock fitting at its first end for releasably connecting to the female Luer lock fitting of the container. Diluent can be passed from the syringe into the container to mix with the concentrated drug and the resultant mixture can then be drawn from the container for administering to a patient.
Patent AT-E297786-T1 (AT)
Inventor: TEPPER JOHN C
IPC: A61N1/40
Filed: 1999-07-30
Granted: 2005-07-15
Abstract: A method for providing electromagnetic therapy to a patient includes placing the patient in proximity to an electromagnetic therapy apparatus. The electromagnetic therapy apparatus includes an electrical circuit for generating an electrical drive signal, a first transducer coil and a second transducer coil for generating respective electromagnetic fields in response to the drive signal, a first portion with a configuration corresponding generally with a chair seat, and a second portion with a configuration corresponding generally with a chair back. The first transducer coil is disposed within the first portion and the second transducer coil is disposed within the second portion. The method further includes stimulating the patient with a pulsed electromagnetic field from at least the first and second transducer coils. The pulsed electromagnetic field having a number of pulses, each pulse having a pulse period of ten microseconds to twenty microseconds.
Patent AT-E352306-T1 (AT)
Inventor: VAN DYKE KNOX
IPC: A61K45/00
Filed: 1999-08-02
Granted: 2007-02-15
Abstract: Damage to cells, tissue and other body parts in a mammalian host may be treated by using hypoxanthine and in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, neurodegenerative disease and damage caused by radiation therapy, high oxygen tension, and chemotherapy.
Patent AT-E225832-T1 (AT)
Inventor: VOGLER CONNY
IPC: C08L21/00
Filed: 1999-08-28
Granted: 2002-10-15
Abstract: The inventive carbon black is characterised by an STSA surface of between 20 and 180 m<2>/g, a 24M4-DBP-absorption of between 40 and 140 ml/100g, a specific BET surface of between 20 and 250 m<2>/g, in that it contains 0.01 to 20 wt % silicon in relation to its total weight and in that it has a ratio of tan delta 0/tan delta 60 greater than 3.37-0.0068•STSA. The inventive carbon black is produced by adding silicon-containing compounds are added and mixed with the of carbon black raw material during the oxidative pyrolysis of the same and optionally, using carbon black oil as the fuel. The inventive carbon black can be used as a filler in rubber mixtures, preferably for tyres.
Patent AT-E242492-T1 (AT)
Inventor: DEADMAN HARRY ALEXANDER
IPC: G01S13/74
Filed: 1999-09-08
Granted: 2003-06-15
Abstract: A proximity measuring apparatus (70) comprises an interrogator (80) for generating an interrogation signal encoded with a reference signature code comprising concatenated codes and emitting it as interrogating radiation. It also incorporates a transponder (90) for receiving the interrogating radiation, demodulating it to extract its signature code and then remodulating it after a delay period to provide a signal for reemission as return radiation therefrom. The interrogator (80) receives return radiation at its antenna (260) and demodulates it to extract its signature code and then correlates the code with the reference code to determine mutual correlation thereof. The interrogator (80) incorporates a computer (290) for controlling a scan direction of the antenna (260) and for measuring time delay between emission of the interrogating radiation therefrom and receipt of corresponding return radiation. The computer (290) computes distance and relative bearing of a transponder (90) providing the return radiation from the scan direction and the time delay. The apparatus (70) may be used for improving road vehicle safety.
Patent AT-E320411-T1 (AT)
Inventor: ZAKOSHANSKY VLADIMIR MIKHAILOV
IPC: C07B61/00
Filed: 1999-09-03
Granted: 2006-04-15
Abstract: Disclosed is a process for the cleavage of technical cumene hydroperoxide (CHP) into phenol, acetone and  alpha -methylstyrene. In a first stage, the CHP cleavage process is conducted in such a way to maintain the heat generation rate and the heat removal rate balanced in each of the CHP cleavage reactors. The cleavage of the CHP is conducted under substantially isothermal conditions at a temperature in the range of 47-50  DEG C. In the second stage of the process dicumylperoxide (DCP) and dimethylbenzene alcohol (DMBA) cleavage is carried out in a multi-section plug-flow reactor under non-isothermal conditions at a controlled temperature increase. The temperature is controlled with the use of thermocouples installed in each section of the reactor. The obtained temperature profile is compared with the temperature profile required by the kinetic model based on  DELTA T in each section of the reactor. Based on any obtained fluctuations at least one of the amount of water additionally fed to the reactor, the temperature and the degree of sulfuric acid conversion into NH4HSO4 are adjusted.
Patent AT-E477273-T1 (AT)
Inventor: VASQUEZ MAXIMILIANO
IPC: C12N15/09
Filed: 1999-11-29
Granted: 2010-08-15
Abstract: The invention provides humanized immunoglobulins that bind to and neutralize gamma-interferon. The antibodies are useful for treatment of diseases of the immune system, particularly autoimmune diseases.
Patent AT-E224998-T1 (AT)
Inventor: SCHIERZ CLAUS
IPC: B01J33/00
Filed: 1999-12-14
Granted: 2002-10-15
Abstract: A bearing mat for supporting an exhaust gas catalyst is configured as a binding agent-free, multi-layered flat structure made of thermally stable threads mechanically reinforced by quilting seams. The threads consist of a crimped yarn composed of filaments and are fixed in the flat structure by the quilting seams under tensile stress. The quilting seams are sewn using a thread whose thermal stability is lower than the mat's operating temperature. A process for producing the mat is also provided, in which crimped yarn composed of thermally stable filaments is withdrawn from rolls in several strands and placed under tension on a transporting device moving transversely to the take-off direction in order to form a multi-layered flat structure. The flat structure moved forward by the transporting device is mechanically reinforced with quilting seams so that the threads remain under tension after the flat structure is removed from the transporting device.
Patent AT-E323508-T1 (AT)
Inventor: JANSEN KATHRIN U
IPC: A61K39/00
Filed: 1999-12-14
Granted: 2006-05-15
Abstract: The invention is a series of synthetic virus-like particles comprising a heterologous conformational epitope useful in the characterization of human papillomavirus infection, and useful to vaccinate individual for protection against HPV 6 and HPV 11 infections, and assays employing the synthetic virus-like particles.
Patent DE-276752-T1 (DE)
IPC: A61K31/395
Filed: 1988-01-21
Abstract: 3-L-pyroglutamoyl-thiazolidine-4-carboxylic acid, prepared starting from an activated ester of L-pyroglutamic acid from pyroglutamoyl chloride and L-thiazolidine-4-carboxylic acid, exhibits interesting immunostimulant, antitoxic, antiinflammatory, antioxidant and anti-aging properties.
Patent DE-874791-T1 (DE)
Inventor: TEMPE MAURICE
IPC: C05F17/02
Filed: 1997-01-17
Abstract: A method for biologically decomposing organic materials, wherein the organic materials are mixed with a structuring material and loaded into a biological decomposition reactor. The reactor used is a channel open at both ends and divided into at least three sections of equal lengths, with air suction/blowing devices in the lower portion and a water discharge device. The mixture of the organic materials and the structuring material is fed into the first section in which air suction is generated for a predetermined time; the resulting material is turned over and transferred to the second section, and the treatment is continued under air suction conditions for as long as in the previous section; and the resulting material is turned over and transferred to the third section, and the treatment is continued under air suction or air blowing conditions for as long as in the previous sections. The method is particularly suitable for treating plant waste or waste water treatment sludge, and may advantageously be used for parallel and simultaneous treatment thereof.
Patent ES-2237352-T1 (ES)
Inventor: HOPWOOD IAN
IPC: F16B7/04
Filed: 2003-01-30
Abstract: A coupling device for the coupling of reinforcing bars, the coupling device comprising an elongate tubular body configured for receiving reinforcing bars, in particular their end portions, at least one recessed gripping surface being formed on an inner surface of the elongate tubular body, the recessed gripping surface comprising a plurality of teeth being configured to engage the reinforcing bars in response to the engagement of the reinforcing bars by a plurality of engaging bolts being adjustably positioned through the elongate tubular body.
Patent ES-2051670-T1 (ES)
Inventor: GERGELY GERHARD
IPC: A61K9/46
Filed: 1990-11-09
Abstract: An uncoated compressed tablet which is used for the preparation of an orally applicable aqueous suspension or solution of a pharmaceutically active substance contains a mixture of the pharmaceutically active substance, a swelling disintegrant and an effervescent system. The weight ratio of the disintegrant to the effervescent system is from 0.1:1 to 4:1.
Patent ES-2037639-T1 (ES)
Title: Aparato para pesar, con cuerpo de prueba que lleva calibres de esfuerzos.
IPC: G01G19/44
Filed: 1992-06-17
Abstract: EL APARATO DE PESADO COMPRENDE UN ZOCALO (1) Y UN PLATO (2) RECEPTOR DE LA CARGA A PESAR, PARALELO A DICHO ZOCALO, EXTENDIENDOSE UN CUERPO DE PRUEBA (3) ENTRE EL ZOCALO (1) Y EL PLATO (2) CUYOS EXTREMOS OPUESTOS (3A, 3B) ESTAN FIJADOS RIGIDAMENTE RESPECTIVAMENTE AL ZOCALO (1) Y AL PLATO (2), COMPRENDIENDO UNA (3C) DE LAS CARAS DEL CUERPO DE PRUEBA (3) CALIBRES DE TENSION ASOCIADOS A UN CIRCUITO ELECTRICO. EL CUERPO DE PRUEBA (3) MOLDEADO EN UNA SOLA PIEZA CON EL ZOCALO 81) Y EL PLATO (2), ES VACIADO. UTILIZACION PARTICULARMENTE PARA REALIZAR PESOS DE PESAPERSONAS.
Patent CY-1107534-T1 (CY)
Title: Αναμειξιμα με νepο διαλυματα αζαλιδων
Inventor: MACY LOWELL R
IPC: A61K9/08
Filed: 2007-01-25
Abstract: Αναμείξιμες με νερό φαρμακευτικές συνθέσεις οι οποίες περιέχουν έως περίπου 40% μιας μακρολίδης όπως ένα αζαλιδικό αντιβιοτικό παρασκευάζονται με αντίδραση της μακρολίδης με οξύ σε ένα μη-υδατικό αναμείξιμο με νερό σύστημα οργανικών διαλυτών.
Patent CY-1107649-T1 (CY)
Inventor: NIYIKIZA CLET
IPC: A61K31/525
Filed: 2007-06-07
Abstract: A method of administering an antifolate to a mammal in need thereof, comprising administering an effective amount of said antifolate in combination with a methylmalonic acid lowering agent.
Patent CY-1106927-T1 (CY)
Title: Φαρμακευτικη συνθεση ενος pde4 ή pde3/4 αναστολεα και ανταγωνιστη υποδοχεα ισταμινης
Inventor: BEUME ROLF
IPC: A61P11/00
Filed: 2007-10-11
Abstract: Η εφεύρεση αφορά την συνδυασμένη χορήγηση των PDE4 ή PDE3/4 αναστολέων και ανταγωνιστών υποδοχέα ισταμίνης για την θεραπευτική αγωγή αναπνευστικών ασθενειών.
Patent CY-1110351-T1 (CY)
Inventor: WUTHRICH PATRICK
IPC: A61K47/32
Filed: 2008-06-10
Abstract: Controlled release solid pharmaceutical compositions containing an active material and one or more polymethacrylates. The compositions are prepared by thermoforming a mixture of the active material and the polymethacrylate(s), the release properties being determined by the nature of the polymethacrylate(s), their relative amounts, and the technique used to make the compositions. Preferably the polymethacrylate(s) are Eudragit (RTM) RL and/or RS, optionally with Eudragit E. The ingredients are mixed and then thermoformed at 60 - 150 degrees C, preferably 80 - 130 degrees C by an extrusion or injection process. The use of a co-extrusion or co-injection procedure, in which the inner and outer layers have different compositions is particularly preferred. Additional components that may be incorporated include antioxidants, flavors, colors, preservatives, sweeteners, and anti-adherents.
Patent CY-1108509-T1 (CY)
Inventor: EDWIN EMIL
IPC: C01B3/26
Filed: 2008-11-13
Abstract: Process for the preparation of fibrous carbon which comprises contacting a metallic catalyst with a carbon-containing gas at elevated temperature, characterized in that said catalyst is sponge iron.
Patent CY-1109881-T1 (CY)
Inventor: OKU NAOTO
IPC: A61K38/10
Filed: 2010-02-25
Abstract: Angiogenesis-specific peptides which home selectively to neovascular tissues and comprise one of the peptides having the amino acid sequences shown in SEQ ID NOS: 1 to 17 and dendrimers thereof. These peptides are applicable to DDS preparations whereby drugs can be transported selectively to target cancer tissues and are useful as diagnostics for cancer, remedies for cancer, etc. which contribute to the improvement in the therapeutic effects on cancer.
Patent CY-1111891-T1 (CY)
Inventor: SCHOETTLI THEODOR
IPC: A61K47/18
Filed: 2011-04-05
Abstract: Between the plunger head (11) and the shaft (15) of the injection syringe lies a guide plate (51), which is connected to the shaft (15) by means of fine links (29). The links (29) break at the latest at the end of the injection procedure. The plunger head (11) can no longer be pulled back and is lost in the syringe barrel (3) so that the syringe (1) cannot be reused.
Patent CY-1113041-T1 (CY)
Inventor: LINDEN PAOLO
IPC: B65D17/34
Filed: 2012-06-06
Abstract: A container for substances comprises an upper wall, which functions as a lid, with a central zone on which a closed line of weakening defines a stopper, in the shape of a tongue, which normally closes a relative aperture for the substance to pass through; a lever, associated with the tongue, which can be driven so as to remove the stopper, at least partly, from the upper wall, detaching it along the line of weakening and thus freeing the aperture; and a connection element of the flexible type which is connected both to the stopper and also to the upper wall. The lever has a first end pivoted in correspondence with a peripheral rib, a second end, which functions as a gripper element, disposed in substantial correspondence with the central zone, and an intermediate zone between the two ends, wherein the lever is connected to the stopper.
Patent CY-1113409-T1 (CY)
Title: Αναστολεις ακτ και ρ70 s6 κινασης
Inventor: DALLY ROBERT DEAN
IPC: C07D473/00
Filed: 2012-10-05
Abstract: Η παρούσα εφεύρεση παρέχει αναστολείς ΑΚΤ και p70 S6 κινάσης του Τύπου (I). Η παρούσα εφεύρεση παρέχει επίσης φαρμακευτικές συνθέσεις που περιέχουν ενώσεις του Τύπου (I), χρήσεις των ενώσεων του Τύπου (I) και μεθόδους χρήσεως των ενώσεων του Τύπου (I).
Patent CY-1114137-T1 (CY)
Title: Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ανδρογονο
Inventor: GYURIK ROBERT
IPC: A61K47/32
Filed: 2013-02-06
Abstract: Μια φαρμακευτική σύνθεση η οποία περιλαμβάνει: (Α) ένα ανδρογόνο· (Β) έναν κυκλικό ενισχυτή του τύπου που χρησιμοποιείται στις συνθέσεις και μεθόδους που αξιώνονται από το Δίπλωμα Ευρεσιτεχνίας των ΗΠΑ No. 5,023,252 του Hsieh· και (C) έναν παράγοντα αύξησης του ιξώδους· περιλαμβάνοντας, για παράδειγμα, μια σύνθεση στην οποία ο κυκλικός ενισχυτής είναι ένας μακροκυκλικός εστέρας ή μια μακροκυκλική κετόνη· τη χρήση της σύνθεσης για την αντιμετώπιση μιας κατάστασης, για παράδειγμα, ανδρικού υπογοναδισμού, σε έναν ασθενή μέσω εφαρμογής της σύνθεσης στη μεμβράνη του ασθενούς· και μια μέθοδο παρασκευής της σύνθεσης.
Patent CY-1115192-T1 (CY)
Title: Αναδιαμορφωση και γλυκοσυζευξη παραγοντα αναπτυξης ινοβλαστης (fgf)
Inventor: DE FREES SHAWN
IPC: C07K1/13
Filed: 2014-05-26
Abstract: Η εφεύρεση περιλαμβάνει μεθόδους και συνθέσεις για αναδιαμόρφωση μορίου πεπτιδίου, που συμπεριλαμβάνει την προσθήκη ή την απαλοιφή μιας ή περισσοτέρων γλυκοζύλ ομάδων σε ένα πεπτίδιο, ή/και την προσθήκη μιας τροποποιημένης ομάδας πεπτιδίου.
Patent CY-1117957-T1 (CY)
Title: Συμπληρωμενο omv εμβολιο εναντι μηνιγγιοκοκκου
Inventor: PIZZA MARIAGRAZIA
IPC: A61K39/295
Filed: 2016-08-29
Abstract: Σύνθεση περιλαμβάνουσα (a) φλύκταινες εξωτερικής μεμβράνης Neisseria meningitidis οροομάδας Β (OMVs) και (b) ανοσογονικό συστατικό που επιλέγεται από άλλες πρωτεΐνες Neisseria, ή ανοσογονικά θραύσματα αυτών. Το συστατικό (b) κατά προτίμηση περιλαμβάνει πρωτεΐνη από διαφορετικό NmB στέλεχος από αυτό από το οποίο λαμβάνεται το OMV συστατικό (a). Τα OMVs κατά προτίμηση λαμβάνονται με εκχύλιση δεοξυχολικού. Προαιρετικώς, η σύνθεση μπορεί επίσης να περιλαμβάνει προστατευτικό αντιγόνο έναντι άλλων παθογόνων.
Patent CY-1120173-T1 (CY)
Title: Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης
Inventor: MOTOMURA TAKAHISA
IPC: C07D231/12
Filed: 2018-04-20
Abstract: Mια ένωση που αντιπροσωπεύεται από τον ακόλουθο τύπο: όπου το n είναι 1 ή 2, ή ένα φαρμακευτικά αποδεκτό άλας αυτής και μια φαρμακευτική χρήση αυτής.